Indirect Treatment Comparison of Ustekinumab Versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Anti‐TNF Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 708. (October 2017)